Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation

• Lauren Bourke,

  Affiliations Centre for Rheumatology, Division of Medicine University College London, Rayne Institute, London, United Kingdom, Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom

  ⨯
• James McCormick,

  Affiliation Biochemistry Research Group, Clinical and Molecular Genetics Unit, Institute of Child Health & Great Ormond Street Hospital, University College London, London, United Kingdom

  ⨯
• Valerie Taylor,

  Affiliation UCL Centre for Advanced Biomedical Imaging, Division of Medicine, London, United Kingdom

  ⨯
• Charis Pericleous,

  Affiliation Centre for Rheumatology, Division of Medicine University College London, Rayne Institute, London, United Kingdom

  ⨯
• Benoit Blanchet,

  Affiliation Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Unité Fonctionnelle de Pharmacocinétique et Pharmacochimie, Paris, France

  ⨯
• Nathalie Costedoat-Chalumeau,

  Affiliation Université René Descartes; Centre de référence maladies auto-immunes et systémiques rares, Service de Médecine Interne, Pôle médecine, Hôpital Cochin, AP-HP, Paris, France

  ⨯
• Daniel Stuckey,

  Affiliation UCL Centre for Advanced Biomedical Imaging, Division of Medicine, London, United Kingdom

  ⨯
• Mark F. Lythgoe,

  Affiliation UCL Centre for Advanced Biomedical Imaging, Division of Medicine, London, United Kingdom

  ⨯
• Anastasis Stephanou,

  Current address: School of Medicine, European University, Nicosia, Cyprus

  Affiliation Medical and Molecular Biology Unit, University College London, London, United Kingdom

  ⨯
• Yiannis Ioannou

  * E-mail: y.ioannou@ucl.ac.uk

  Affiliations Centre for Rheumatology, Division of Medicine University College London, Rayne Institute, London, United Kingdom, Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom

  ⨯